Share Name Share Symbol Market Type Share ISIN Share Description
Proteome LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.025p +0.49% 5.10p 5.00p 5.24p 5.25p 5.10p 5.25p 220,000.00 08:02:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -2.9 -1.0 - 15.03

Proteome Sciences PLC Holding(s) in Company

16/12/2016 9:28am

UK Regulatory (RNS & others)


TIDMPRM

RNS Number : 0712S

Proteome Sciences PLC

16 December 2016

 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
-------------------------------------------------- 
 
 
 
 1. Identity of the issuer or                               PROTEOME SCIENCES PLC 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
---------------------------------------------------------  --------------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
-------------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                            YES 
----------------------------------------------------------  -------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
----------------------------------------------------------  -------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
----------------------------------------------------------  -------------------------- 
 An event changing the breakdown of voting rights 
----------------------------------------------------------  -------------------------- 
 Other (please 
  specify): 
--------------------------------------------------------    -------------------------- 
 3. Full name of person(s)                                  VULPES LIFE SCIENCES FUND 
  subject to the 
  notification obligation: 
  (iii) 
---------------------------------------------------------  --------------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
---------------------------------------------------------  --------------------------- 
 5. Date of the transaction                                 14 DECEMBER 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
---------------------------------------------------------  --------------------------- 
 6. Date on which issuer                                    15 DECEMBER 2016 
  notified: 
---------------------------------------------------------  --------------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                        18% 
---------------------------------------------------------  --------------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                Resulting situation after the 
  of             to the triggering                 triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  --------------------------------  --------------------------------------------------------------------- 
                Number           Number           Number         Number of voting             % of voting 
                 of               of               of shares      rights                       rights (x) 
                 Shares           Voting 
                                  Rights 
-------------  ---------------  ---------------  -------------  ---------------------------  ------------------------- 
                                                  Direct         Direct         Indirect      Direct        Indirect 
                                                                  (xi)           (xii) 
-------------      -----------    -----------    -------------  -------------  ------------  ------------  ----------- 
 GB0003104196   36,573,125       36,573,125       52,973,125     52,973,125                   18.00% 
               ---------------  ---------------  -------------  -------------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration     Exercise/                       Number of voting               % of voting 
 financial           date           Conversion                      rights that                    rights 
 instrument          (xiii)         Period (xiv)                    may be 
                                                                    acquired if 
                                                                    the 
                                                                    instrument is 
                                                                    exercised/ converted. 
-----------------  -------------  ------------------------------  -----------------------------  --------------------- 
 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise       Expiration     Exercise/        Number of voting               % of voting 
 financial         price         date           Conversion        rights instrument              rights 
 instrument                      (xvii)         period            refers to                      (xix, xx) 
                                                (xviii) 
---------------  -------------  -------------  ---------------  -----------------------------  ----------------------- 
                                                                                                Nominal       Delta 
---------------  -------------  -------------  ---------------  -----------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                            Percentage of voting rights 
-------------------------------------------------  ------------------------------------------------------------------- 
 52,973,125                                         18.00% 
-------------------------------------------------  ------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
--------------------------------------------------------------------------------------------- 
 
 
 Proxy Voting: 
--------------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
--------------------------------------------------------------  ----------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
--------------------------------------------------------------  ----------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
--------------------------------------------------------------  ----------------------------- 
 
                                                              executive.pa@proteomics.com 
  13. Additional information: 
------------------------------------------------------------  ------------------------------- 
 14. Contact name:                                             Victoria Birse 
------------------------------------------------------------  ------------------------------- 
 15. Contact telephone number: 
------------------------------------------------------------  ------------------------------- 
 
 
 
 Note: Annex should only be submitted to the FCA not 
  the issuer 
 Annex: Notification of major interests in share 
 
 A: Identity of the persons or legal entity subject to 
  the notification obligation 
----------------------------------------------------------------------- 
 Full name                             VULPES LIFE SCIENCES FUND 
  (including legal form of 
  legal entities) 
------------------------------------  --------------------------------- 
 Contact address                       c/o Maples Corporate Services 
  (registered office for legal          Limited, PO 
  entities)                             Box 309, Ugland House, Grand 
                                        Cayman, KY1-1104, Cayman 
                                        Islands 
------------------------------------  --------------------------------- 
 Phone number & email 
------------------------------------  --------------------------------- 
 Other useful information 
  (at least legal representative 
  for legal persons) 
------------------------------------  --------------------------------- 
 
 B: Identity of the notifier, if applicable 
----------------------------------------------------------------------- 
 Full name                             Stephen Diggle 
------------------------------------  --------------------------------- 
 Contact address                       One George Street #07-03 
                                        Singapore 049145 
------------------------------------  --------------------------------- 
 Phone number & email                  Tel: (65) 6538 1998 (Main) 
                                        Email: sdiggle@vulpesinvest.com 
------------------------------------  --------------------------------- 
 Other useful information              Director 
  (e.g. functional relationship 
  with the person or legal 
  entity subject to the notification 
  obligation) 
------------------------------------  --------------------------------- 
 
 C: Additional information 
----------------------------------------------------------------------- 
 Email address: Complete the required TR-1 form and email 
  it to: Major shareholdings majorshareholdings@fca.gov.uk 
  Fax number: You can print the TR-1 form, complete it 
  and fax it to: 020 7066 0050 
----------------------------------------------------------------------- 
 For notes on how to complete form TR-1 please see the 
  FCA website. 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLGGGAPPUPQUBQ

(END) Dow Jones Newswires

December 16, 2016 04:28 ET (09:28 GMT)

1 Year Proteome Chart

1 Year Proteome Chart

1 Month Proteome Chart

1 Month Proteome Chart
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V:gb D:20170427 07:19:25